AZTR

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Azitra Inc

NYSE MKT | AZTR

0.70

USD

$0.00

(

0.00%

)

At Close (As of Oct 16, 2025)

$3.82M

Market Cap

0.0262

P/E Ratio

26.97

EPS

$4.33

52 Week High

$0.67

52 Week Low

HEALTHCARE

Sector

AZTR Chart

Recent Chart
Price Action

AZTR Technicals

Tags:

AZTR Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $7.5M
Total Revenue $7.5M
Cost Of Revenue $448K
Costof Goods And Services Sold $448K
Operating Income -$11B
Selling General And Administrative $6.3B
Research And Development $4.7B
Operating Expenses $11B
Investment Income Net -
Net Interest Income $110K
Interest Income $123K
Interest Expense $12K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $448K
Income Before Tax -$9B
Income Tax Expense $9K
Interest And Debt Expense -
Net Income From Continuing Operations -$9M
Comprehensive Income Net Of Tax -
Ebit -$8.9M
Ebitda -$8.5M
Net Income -$9M

Revenue & Profitability

Earnings Performance

AZTR Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $7.4M
Total Current Assets $5.2M
Cash And Cash Equivalents At Carrying Value $4.6M
Cash And Short Term Investments $4.6M
Inventory -
Current Net Receivables $102K
Total Non Current Assets $2.1M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $246K
Intangible Assets Excluding Goodwill $246K
Goodwill $246M
Investments -
Long Term Investments -
Short Term Investments -$4.6B
Other Current Assets $568K
Other Non Current Assets -
Total Liabilities $1.7M
Total Current Liabilities $1.4M
Current Accounts Payable $490K
Deferred Revenue -
Current Debt -
Short Term Debt $271K
Total Non Current Liabilities $285K
Capital Lease Obligations $556K
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $556K
Other Current Liabilities $603K
Other Non Current Liabilities -
Total Shareholder Equity $5.7M
Treasury Stock -
Retained Earnings -$58M
Common Stock $763
Common Stock Shares Outstanding $568K

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$10M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $448K
Capital Expenditures $8.6K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$379K
Cashflow From Financing $13M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$9M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $7.5M
Total Revenue $7.5M
Cost Of Revenue $448K
Costof Goods And Services Sold $448K
Operating Income -$11B
Selling General And Administrative $6.3B
Research And Development $4.7B
Operating Expenses $11B
Investment Income Net -
Net Interest Income $110K
Interest Income $123K
Interest Expense $12K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $448K
Income Before Tax -$9B
Income Tax Expense $9K
Interest And Debt Expense -
Net Income From Continuing Operations -$9M
Comprehensive Income Net Of Tax -
Ebit -$8.9M
Ebitda -$8.5M
Net Income -$9M

AZTR Profile

Azitra Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Azitra Inc (AZTR) is a pre-clinical biopharmaceutical company headquartered in Branford, Connecticut, specializing in precision dermatology through innovative therapeutic solutions. By harnessing advanced technologies such as engineered proteins and live biotherapeutic products, Azitra aims to create targeted treatments for a range of skin disorders. With a commitment to enhancing patient outcomes in dermatological care, the company is strategically positioned to lead advancements in skin disease management and contribute significant advancements in the biopharmaceutical landscape.

VHAI
-20.00%
$0.00
VIVK
-1.72%
$0.28
YYAI
-10.71%
$0.12
BURU
+1.09%
$0.34
RXRX
-6.33%
$6.36
EPWK
+26.46%
$0.09
BITF
-18.39%
$5.28
IVF
+85.67%
$1.40
NAYA
+85.67%
$1.40
CGBS
-39.47%
$0.03
NVDA
+1.10%
$181.81
PLUG
-8.70%
$3.51
YDKG
-49.73%
$0.09
ADAP
+6.02%
$0.19
BYND
-22.39%
$0.52
NVTS
+3.10%
$15.63
RGTI
-14.85%
$47.97
DNN
-2.83%
$3.08
NIO
-1.09%
$6.74
MIRA
+36.36%
$1.80
F
-0.17%
$11.74
SCNX
-17.63%
$0.58
BBD
+1.71%
$3.25
AADI
+24.28%
$2.61
KVUE
-13.22%
$14.11
ACHR
-8.90%
$11.87
INTC
-0.83%
$36.84
TLRY
-8.33%
$1.54
HPE
-10.06%
$22.52
FEMY
+35.37%
$0.74
TSLA
-1.47%
$428.75
IONZ
+19.44%
$3.44
SOFI
-5.10%
$26.60
ONDS
-13.77%
$8.19
CAN
-14.79%
$1.67
AMD
-1.69%
$234.56
DFLI
-32.48%
$1.33
AXDX
-61.36%
$0.03
ETHD
+6.47%
$3.78
RIG
-2.56%
$3.22
AAL
-4.88%
$11.89
CLF
-2.79%
$13.56
MARA
-11.27%
$20.26
GDXD
-10.23%
$0.60
LAES
-15.08%
$6.36
AMC
-2.30%
$2.75
BTBT
-9.11%
$3.69
RF
-5.61%
$23.35
GNPX
-43.39%
$0.47
QBTS
-9.64%
$40.46
BTG
+3.96%
$5.89
VSEE
-13.85%
$0.51
QS
-13.38%
$15.46
RR
-7.95%
$5.67
GPUS
-5.78%
$0.36
LGCB
+19.39%
$1.97
ABAT
-36.64%
$5.67
NAK
-4.34%
$2.64
HBAN
-5.18%
$15.37
SNAP
-1.89%
$7.76
QUBT
-11.72%
$18.73
QSI
-3.42%
$2.54
CIFR
-10.98%
$18.72
RGTZ
+29.08%
$11.23
WOK
+1.55%
$0.05
CRML
-14.52%
$19.42
UUUU
-13.20%
$21.69
CLSK
-13.83%
$19.98
IREN
-9.04%
$61.83
ASST
-6.24%
$0.90
PFE
-0.65%
$24.23
MASK
+17.35%
$0.57
KEY
-5.35%
$16.78
T
+0.49%
$26.20
PLTR
-0.83%
$178.12
SOUN
-2.99%
$20.76
AMZN
-0.51%
$214.47
MU
+5.51%
$202.53
JBLU
-3.63%
$4.76
APLD
-2.96%
$36.64
SMR
-10.87%
$47.62
FNB
-7.21%
$14.65
WTO
-88.87%
$0.13
RMBL
+60.50%
$3.21
GRAB
-3.54%
$5.71
AAPL
-0.75%
$247.45
WULF
-10.40%
$13.86
NOK
+0.35%
$5.67
ADD
-25.47%
$0.05
HIMS
-5.75%
$59.15
AUUD
+0.97%
$2.06
SOND
+79.34%
$1.65
BAC
-4.03%
$50.17
CRWV
+1.79%
$141.74
JOBY
-8.69%
$16.07
SLNH
-2.33%
$4.19
IONQ
-9.41%
$65.59
TOVX
-48.34%
$0.43
SRM
+53.27%
$10.30
SATL
-29.71%
$2.91
VHAI
-20.00%
$0.00
VIVK
-1.72%
$0.28
YYAI
-10.71%
$0.12
BURU
+1.09%
$0.34
RXRX
-6.33%
$6.36
EPWK
+26.46%
$0.09
BITF
-18.39%
$5.28
IVF
+85.67%
$1.40
NAYA
+85.67%
$1.40
CGBS
-39.47%
$0.03
NVDA
+1.10%
$181.81
PLUG
-8.70%
$3.51
YDKG
-49.73%
$0.09
ADAP
+6.02%
$0.19
BYND
-22.39%
$0.52
NVTS
+3.10%
$15.63
RGTI
-14.85%
$47.97
DNN
-2.83%
$3.08
NIO
-1.09%
$6.74
MIRA
+36.36%
$1.80
F
-0.17%
$11.74
SCNX
-17.63%
$0.58
BBD
+1.71%
$3.25
AADI
+24.28%
$2.61
KVUE
-13.22%
$14.11
ACHR
-8.90%
$11.87
INTC
-0.83%
$36.84
TLRY
-8.33%
$1.54
HPE
-10.06%
$22.52
FEMY
+35.37%
$0.74
TSLA
-1.47%
$428.75
IONZ
+19.44%
$3.44
SOFI
-5.10%
$26.60
ONDS
-13.77%
$8.19
CAN
-14.79%
$1.67
AMD
-1.69%
$234.56
DFLI
-32.48%
$1.33
AXDX
-61.36%
$0.03
ETHD
+6.47%
$3.78
RIG
-2.56%
$3.22
AAL
-4.88%
$11.89
CLF
-2.79%
$13.56
MARA
-11.27%
$20.26
GDXD
-10.23%
$0.60
LAES
-15.08%
$6.36
AMC
-2.30%
$2.75
BTBT
-9.11%
$3.69
RF
-5.61%
$23.35
GNPX
-43.39%
$0.47
QBTS
-9.64%
$40.46
BTG
+3.96%
$5.89
VSEE
-13.85%
$0.51
QS
-13.38%
$15.46
RR
-7.95%
$5.67
GPUS
-5.78%
$0.36
LGCB
+19.39%
$1.97
ABAT
-36.64%
$5.67
NAK
-4.34%
$2.64
HBAN
-5.18%
$15.37
SNAP
-1.89%
$7.76
QUBT
-11.72%
$18.73
QSI
-3.42%
$2.54
CIFR
-10.98%
$18.72
RGTZ
+29.08%
$11.23
WOK
+1.55%
$0.05
CRML
-14.52%
$19.42
UUUU
-13.20%
$21.69
CLSK
-13.83%
$19.98
IREN
-9.04%
$61.83
ASST
-6.24%
$0.90
PFE
-0.65%
$24.23
MASK
+17.35%
$0.57
KEY
-5.35%
$16.78
T
+0.49%
$26.20
PLTR
-0.83%
$178.12
SOUN
-2.99%
$20.76
AMZN
-0.51%
$214.47
MU
+5.51%
$202.53
JBLU
-3.63%
$4.76
APLD
-2.96%
$36.64
SMR
-10.87%
$47.62
FNB
-7.21%
$14.65
WTO
-88.87%
$0.13
RMBL
+60.50%
$3.21
GRAB
-3.54%
$5.71
AAPL
-0.75%
$247.45
WULF
-10.40%
$13.86
NOK
+0.35%
$5.67
ADD
-25.47%
$0.05
HIMS
-5.75%
$59.15
AUUD
+0.97%
$2.06
SOND
+79.34%
$1.65
BAC
-4.03%
$50.17
CRWV
+1.79%
$141.74
JOBY
-8.69%
$16.07
SLNH
-2.33%
$4.19
IONQ
-9.41%
$65.59
TOVX
-48.34%
$0.43
SRM
+53.27%
$10.30
SATL
-29.71%
$2.91
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.